These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23117253)

  • 1. The LORS-enabled dialogue: a collaborative intervention to promote recovery from psychotic disorders.
    Sousa SA; Corriveau D; Lee AF; Bianco LG; Sousa GM
    Psychiatr Serv; 2013 Jan; 64(1):58-64. PubMed ID: 23117253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of Recovery Scale (LORS): psychometric properties of a new instrument to assess psychotic symptoms and patient awareness.
    Corriveau DP; Sousa S
    Psychol Rep; 2013 Oct; 113(2):435-40. PubMed ID: 24597439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LORS-enabled dialogue: improving insight in psychotic illnesses.
    Sousa S
    J Psychosoc Nurs Ment Health Serv; 2008 Feb; 46(2):44-51. PubMed ID: 18293783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-Cutting Symptom Domains Predict Functioning in Psychotic Disorders.
    Longenecker JM; Bagby RM; McKenzie K; Pollock BG; George TP; Voore P; Quilty LC
    J Clin Psychiatry; 2021 Feb; 82(2):. PubMed ID: 33988932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis.
    Twamley EW; Doshi RR; Nayak GV; Palmer BW; Golshan S; Heaton RK; Patterson TL; Jeste DV
    Am J Psychiatry; 2002 Dec; 159(12):2013-20. PubMed ID: 12450950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients.
    Katz G; Durst R; Shufman E; Bar-Hamburger R; Grunhaus L
    Compr Psychiatry; 2010; 51(1):37-41. PubMed ID: 19932824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of "prodromal" symptoms with severity and type of psychopathology in the active phase of schizophrenia.
    Moukas G; Stathopoulou A; Gourzis P; Beratis IN; Beratis S
    Compr Psychiatry; 2010; 51(1):1-7. PubMed ID: 19932819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early intervention with second-generation antipsychotics in first-episode psychosis: results of an 8-week naturalistic study.
    Josiassen RC; Shaughnessy RA; Filymer DM; Donohue AM; Kacso M; Finkel N; Curtis J; Audino B; Skuban N
    Early Interv Psychiatry; 2010 Feb; 4(1):57-63. PubMed ID: 20199481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing patient adherence: outcomes of medication alliance training on therapeutic alliance, insight, adherence, and psychopathology with mental health patients.
    Byrne MK; Deane FP
    Int J Ment Health Nurs; 2011 Aug; 20(4):284-95. PubMed ID: 21729254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis.
    Rabinowitz J; De Smedt G; Harvey PD; Davidson M
    Am J Psychiatry; 2002 Dec; 159(12):2021-6. PubMed ID: 12450951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence and nonadherence to antipsychotic medications.
    Kozuki Y; Schepp KG
    Issues Ment Health Nurs; 2005 May; 26(4):379-96. PubMed ID: 16020055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traumatized refugees: morbidity, treatment and predictors of outcome.
    Buhmann CB
    Dan Med J; 2014 Aug; 61(8):B4871. PubMed ID: 25162447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of patient-rated and clinician-rated illness severity in schizophrenia.
    Fervaha G; Takeuchi H; Agid O; Lee J; Foussias G; Remington G
    J Clin Psychiatry; 2015 Jul; 76(7):924-30. PubMed ID: 25562591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.
    Beck EM; Cavelti M; Wirtz M; Kossowsky J; Vauth R
    Psychiatry Res; 2011 May; 187(1-2):55-61. PubMed ID: 21074860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved insight affects social outcomes in involuntarily committed psychotic patients: a longitudinal study in the Netherlands.
    van Baars AW; Wierdsma AI; Hengeveld MW; Mulder CL
    Compr Psychiatry; 2013 Oct; 54(7):873-9. PubMed ID: 23618608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse.
    Møller T; Linaker OM
    Nord J Psychiatry; 2004; 58(3):237-42. PubMed ID: 15204212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication attitudes and beliefs in patients with psychotic and affective disorders on maintenance treatment.
    Ng CH; Smith DJ; King J; Ong S; Schweitzer I
    Hum Psychopharmacol; 2012 Jan; 27(1):57-62. PubMed ID: 22241683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.